Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. (2018)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(18)31033-x
PubMed Identifier: 29778325
Publication URI: http://europepmc.org/abstract/MED/29778325
Type: Journal Article/Review
Volume: 391
Parent Publication: Lancet (London, England)
Issue: 10135
ISSN: 0140-6736